FindTrial
Sign In

Effect of Remifentanil infusion rate on Surgical Environment in Shoulder Arthroscopic Surgery

Effect of the dose of remifentanil on the surgical conditions in shoulder arthroscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006977
Enrollment
28
Registered
2022-02-03
Start date
2022-01-21
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University Guri Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 28 patients undergoing elective surgical procedures who are between American society of anesthesiologists(ASA) classification I and II, and age between 19 and 69.

Exclusion criteria

Exclusion criteria: 1) Patients with uncontrolled hypertension, 2) Patients with history of myocardial infarction, cerebral infarction and cerebral hemorrhage, 3) Patients with acute kidney injury and chronic kidney disease, 4) patients with blood clotting disorder

Design outcomes

Primary

MeasureTime frame
systolic blood pressue, diastolic blood pressure, meam arterial pressure, heart rate, Bispectral index, stroke volume and cardiac output—

Secondary

MeasureTime frame
visual analog scale score, postoperative nausea and vomiting score—

Countries

Korea, Republic of

Contacts

Public ContactSangyoon Cho

Hanyang University Guri Hospital

chosy@hanyang.ac.kr+82-31-560-2400

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026